• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL1501928 TQ-B3101胶囊 unecritinib fumarate Capsule Chemical Drugs(1.1) New Drug Application 2015-10-29 正大天晴药业集团股份有限公司 Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd Certificate Issued 2016-08-04 view
CXHB2000016 TQ-B3101胶囊 unecritinib fumarate Capsule Chemical Drugs Supplementary Application 2020-03-20 正大天晴药业集团股份有限公司 Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd In Review 2020-03-19 view
CXHB1900049 TQ-B3101胶囊 unecritinib fumarate Capsule Chemical Drugs Supplementary Application 2019-09-12 正大天晴药业集团股份有限公司 Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd In Review 2019-09-11 view
CXHB1900050 TQ-B3101胶囊 unecritinib fumarate Capsule Chemical Drugs Supplementary Application 2019-09-12 正大天晴药业集团股份有限公司 Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd In Review 2019-09-11 view
CXHS2200034 TQ-B3101胶囊 unecritinib fumarate Capsule Chemical Drugs(1) New Drug Application 2022-06-23 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
CXHB2300243 TQ-B3101胶囊 unecritinib fumarate Capsule Chemical Drugs(1) Supplementary Application 2023-11-30 view
CXHB2300195 TQ-B3101胶囊 unecritinib fumarate Capsule Chemical Drugs(1) Supplementary Application 2023-10-09 view
CXHB2300193 TQ-B3101胶囊 unecritinib fumarate Capsule Chemical Drugs(1) Supplementary Application 2023-10-09 view
CXHS2200035 TQ-B3101胶囊 unecritinib fumarate Capsule Chemical Drugs(1) New Drug Application 2022-06-23 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
CXHB2300242 TQ-B3101胶囊 unecritinib fumarate Capsule Chemical Drugs(1) Supplementary Application 2023-11-30 view